Malignant melanoma: A retrospective series from a regional cancer center in India

Journal of Cancer Research and Therapeutics

Volumn 5, Issue 3, 2009, Pages 173-180

  Sharma, Kuldeep ^a   Mohanti, Bidhu ^a   Rath, Gaura K ^a  

^a INSTITUTE ROTARY CANCER HOSPITAL   (India)

Author keywords

India; Management; Melanoma; Radiotherapy; Results

Indexed keywords

CISPLATIN; DACARBAZINE; INTERFERON; TAMOXIFEN; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; BRAIN METASTASIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; INDIA; LYMPH NODE DISSECTION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORBIDITY; MULTIPLE CYCLE TREATMENT; PROGNOSIS; RADIATION DOSE; RISK FACTOR; SKIN DEFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR CLASSIFICATION; ULCER; VISUAL DISORDER;

CANCER CARE FACILITIES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDIA; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS;

EID: 70350317514     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.57122     Document Type: Article

References (33)

1. Chang DT, Amdur RJ, Morris CG, Mendenhall WM. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys 2006;66:1051-1055
2. French J, McGahan C, Duncan G, Lengoc S, Soo J, Cannon J. How gender, age, and geography influence the utilization of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys 2006;66:1056-1063
3. Mowbray M, Stockton DL, Doherty VR. Changes in the site distribution of malignant melanoma in south-east Scotland (1979- 2002). Br J Cancer 2007;96:832-835
4. Rodriquez M, Lee S, Silvers DN, Celebi JT. Influence of age on survival in childhood spitzoit melanomas. Cancer 2007;109:1579-1583
5. Cochran AJ, Glapsy JA, Ribas A, Economou JE. Malignant melanoma of the skin. In: Haskell CM, editor. Cancer treatment. 5th ed. W B Saunders; 2001. p. 1158-1177
6. Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, et al. Combined modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 2006;64:106-113
7. Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, et al. Improvement in overall survival of patients with cutaneous melanoma in Germany, 1976-2001. Which factors contributed? Cancer 2007;109:1174-1182
8. David W Ollila. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol 2006;7:919-924
9. Bonnen MD, Ballo MT, Myers JN, Garden AS, Diaz AM, Gershenwald JE, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004;100:383-389
10. Jost LM, Jelic S, Purklane G. ESMO minimum clinical recommendations for diagnosis, treatment and follow up of cutaneous malignant melanoma. Annals Oncol 2005;16:i66-8. (Pubitemid 40872995)
11. Eicher SA, Clayman GL, Myers JN, Gillenwater AM. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg 2002;128:241-246
12. Pitts JM, Maloney ME. Therapeutic advances in melanoma. Dermalogic clinics 2000;18:157-165
13. Creagon ET, Cupps RE, Ivins JC. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized prospective study. Cancer 1978;42:2206-2210
14. Bastiaannet E, Beukema JC, Hoekstra HJ. Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications. Cancer Treat Rev 2005;31:18-26.
15. Ballo MT, Ang KK. Radiation therapy for malignant melanoma. Surg Clin N Am 2003;83:323-342
16. Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma: A review of the evidence. Cancer 2004;100:1293-1301 (Pubitemid 38325959)
17. Burmeister BH, Mark Smithers B, Burmeister E, Baumann K, Davis S, Krawitz H, et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma . Trans Tasman Radiation Oncology Group (TROG) study 96.06. Radiother Oncol 2006;8:136-142
18. Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: A clinical radiobiologic study. Int J Radiat Oncol Biol Phys 1986;12:867-872
19. Geara FB, Ang KK. Radiation therapy of malignant melanoma. Surg clin North Am 1996;76:1383-1398
20. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1990;20:429-432
21. Gogas HJ, Kirkwood JM, Sondak VK. Chemotherapy for metastatic melanoma: time for a change. Cancer 2007;109:455-464
22. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Chaoying J, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2000;46:467-474
23. Ang KK, Peters LJ, Weber RS,Morrison WH, Frankenthaler RA, Garden AS, Goepfert H, et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys 1994;30:795-798
24. O.Brien CJ, Coates AS, Petersen-Schaefer K, Shannon K, Thompson JF, Milton GW, et al. Experience with 998 cutaceous melanomas of the head and neck over 30 years. Am J Surg 1991;162:310-314
25. Wanebo HJ, Cooper PH, Young DV. Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer 1988;62:831-837
26. Huang J, Zhou S, Groome P, Tyldesley S, Zhang-Solomans J, Mackillop WJ. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol 2001;19:137-144
27. Ballo MT, Bonnen MD, Garden AS, Myers JN, Gershenwald JE, Zagars GK, Schechter NR, et al. Adjuvant irradiation for cervical lymph node metastases from melanoma. Cancer 2003;97:1789-1796
28. Ballo MT, Storm EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, et al. Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2002;52:964-972
29. Seegenschmiedt MH, Keilholz L, Hoffmann AA, Urban A, Schell H, Hohenberger W, et al. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20 year experience. Int J Radiat Oncol Biol Phys 1999;44:607-618 (Pubitemid 29258436)
30. Ziegler JC, Cooper JS. Brain metastases from malignant melanoma: conventional vs high dose per fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986;12:1839-1842
31. Shields CL, Shields JA, Kiratli H, Potter PD, Cater JR. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 1995;102:1351-1361
32. McKinnan JG, Kokal WA, Neifeld JP. Natural history and treatment of mucosal melanoma. J Surg Oncol 1989;41:222-225
33. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2001;19:3622-3634